{"nctId":"NCT02423876","briefTitle":"Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery","startDateStruct":{"date":"2015-03-17","type":"ACTUAL"},"conditions":["Intraoperative Complication","Malignant Female Reproductive System Neoplasm","Pain"],"count":104,"armGroups":[{"label":"Arm I (epidural placement, ERP)","type":"EXPERIMENTAL","interventionNames":["Drug: Epidural analgesia","Other: Intraoperative Complication Management and Prevention","Procedure: Pain Therapy"]},{"label":"Arm II (ERP)","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Intraoperative Complication Management and Prevention","Procedure: Pain Therapy"]}],"interventions":[{"name":"Epidural analgesia","otherNames":["Epidural Block","ropivicaine","hydromorphone","Naropin","Dilaudid","Exalgo"]},{"name":"Intraoperative Complication Management and Prevention","otherNames":["Intraoperative Complication Management/Prevention"]},{"name":"Pain Therapy","otherNames":["Analgesia","Pain Control","Pain Management","Pain, Pain Management"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients undergoing gynecologic surgery via midline vertical laparotomy at University of Wisconsin Hospital and Clinics (UWHC)\n* Patients must be English speaking\n* Patients must have the ability to understand visual and verbal pain scales\n* Patients must be eligible for epidural placement\n\nExclusion Criteria:\n\n* Known allergy to local anesthetics\n* Known history of chronic pain disorders and/or chronic opioid use defined as \\> 10 mg of oral (PO) morphine or equivalent used daily for at least 30 days prior to enrollment\n* Patient is a prisoner or incarcerated\n* Significant liver disease that would inhibit prescription of opioids\n* Significant kidney disease that would inhibit administration of gabapentin\n* Patient has a history of opioid dependence requiring rehabilitation or the use of opioid antagonists\n* Patient is pregnant\n* Patients with a planned exploration with biopsies (no organs removed) will be excluded from the study","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Relative Pain Scores, as Measured by the Pain Numeric Rating Scale (NRS)","description":"Relative pain scores between the epidural and non-epidural group will be analyzed by calculating a two-sided 95% confidence interval on the difference in mean scores between the two groups and concluding non-inferiority if this lies entirely below 2 points (mean non-epidural pain score proven, within a 95% confidence limit, to be at most 2 points worse than mean pain score in the epidural group). NRS rates pain on a 1-10 scale, with 1 being no pain, and 10 being the worst pain imaginable.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.87","spread":null},{"groupId":"OG001","value":"4.95","spread":null}]}]}]},{"type":"SECONDARY","title":"Average Daily Pain Score as Measured by Pain NRS Scores","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.98","spread":null},{"groupId":"OG001","value":"5.12","spread":null}]}]}]},{"type":"SECONDARY","title":"Difference in IL-2 Levels Between Pre-operative and Post-operative Values","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.6","spread":null},{"groupId":"OG001","value":"15.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Epidural Discontinuation Rates Prior to Planned Removal (in Epidural Group Only)","description":"Will be tabulated and presented for each group (where applicable).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Hospital Stay (Hours)","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99.83","spread":null},{"groupId":"OG001","value":"87.25","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Time Until Return of Bowel Function","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.22","spread":null},{"groupId":"OG001","value":"2.20","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Recorded Episodes of Emesis","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".192","spread":null},{"groupId":"OG001","value":".1875","spread":null}]}]}]},{"type":"SECONDARY","title":"Patient Satisfaction Scores Related to Pain Metrics, as Measured by the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap. Scores range from 1 to 4, with higher scores indicating higher satisfaction.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.78","spread":null},{"groupId":"OG001","value":"3.87","spread":null}]}]}]},{"type":"SECONDARY","title":"Post-operative Antiemetic Use (Measured in mg of Ondanestron Used in the First 24 Hours After Surgery)","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.46","spread":null},{"groupId":"OG001","value":"3.17","spread":null}]}]}]},{"type":"SECONDARY","title":"Post-operative Complications (UTIs, Thromboembolic Events, Pneumonia, Blood Transfusion, Myocardial Infarction, Falls)","description":"\\# of events in each group will be reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Readmission Rate","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Opioid Use Measured in Oral Morphine Equivalents (mg)","description":"Will be compared using two-sided 95% confidence intervals for their mean differences. Superiority tests at the two-sided .05 level will be conducted by determining whether these confidence intervals overlap.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"50.1","spread":null},{"groupId":"OG001","value":"82.56","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":52},"commonTop":["anemia","vascular thrombolic event"]}}}